Evaluating the Role of Aspirin in Liver Disease: Efficacy, Safety, Potential Benefits and Risks
The rise in liver disease incidence and prevalence has led to increasing morbidity and mortality worldwide. Persistent hepatic inflammation drives disease progression by increasing fibrosis, advancing to cirrhosis, and potentially developing into hepatocellular carcinoma (HCC). Addressing these comp...
Saved in:
| Main Authors: | Amani Elshaer, Blanca C. Lizaola-Mayo |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Life |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2075-1729/14/12/1701 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
by: Hai Xu, et al.
Published: (2025-04-01) -
The association of chronic pain, painkiller use, and potential mediators with liver fat content
by: Yu Cheng, et al.
Published: (2025-02-01) -
Natural History of Metabolic Dysfunction-Associated Steatotic Liver Disease: From Metabolic Syndrome to Hepatocellular Carcinoma
by: Melchor Alpízar Salazar, et al.
Published: (2025-01-01) -
Chronic Inflammation and Immune Dysregulation in Metabolic-Dysfunction-Associated Steatotic Liver Disease Progression: From Steatosis to Hepatocellular Carcinoma
by: Young-Min Jee, et al.
Published: (2025-05-01) -
Pathogenic Mechanisms of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)-Associated Hepatocellular Carcinoma
by: Toru Nakamura, et al.
Published: (2025-03-01)